Cefixime Dosing: Once Daily (OD) or Twice Daily (BID)?
Cefixime can be administered either once daily (400 mg OD) or twice daily (200 mg BID), with both regimens demonstrating equivalent efficacy for most indications. However, the twice-daily regimen may be better tolerated with fewer gastrointestinal side effects.
FDA-Approved Dosing Regimens
The FDA label for cefixime explicitly provides flexibility in dosing 1:
- Adults: 400 mg daily, which may be given as a single 400 mg dose once daily
- Pediatric patients (≥6 months): 8 mg/kg/day, which may be administered as a single daily dose OR divided into two doses of 4 mg/kg every 12 hours
For uncomplicated gonorrhea specifically: A single oral dose of 400 mg is recommended 1.
Clinical Evidence Supporting Both Regimens
Pharmacokinetic Data
Multiple-dose pharmacokinetic studies demonstrate that both regimens achieve steady-state without drug accumulation 2:
- 200 mg BID: Mean peak serum concentrations of 1.67-1.87 μg/mL with trough levels averaging 0.40 μg/mL
- 400 mg OD: Mean peak serum concentrations of 2.67-3.04 μg/mL (1.5-2.2 times higher than BID) with trough levels averaging 0.08 μg/mL
- Urinary excretion was comparable: 11.9-14.5% (BID) vs 9.9-12.4% (OD) over 15 days
Key finding: No accumulation occurred with either regimen over 15 days of dosing 2.
Clinical Efficacy
Clinical trials in urinary tract infections and respiratory infections demonstrate comparable efficacy between once-daily and twice-daily dosing 3, 4:
- Both regimens showed similar clinical and bacteriological cure rates
- In pediatric otitis media studies, 8 mg/kg daily (given either as single dose or divided BID) was equally effective 1
Tolerability Considerations: A Critical Distinction
The twice-daily regimen (200 mg BID) demonstrates superior gastrointestinal tolerability compared to once-daily dosing (400 mg OD) 5, 6:
- Once-daily dosing showed a higher incidence of gastrointestinal adverse effects (diarrhea and stool changes in up to 20% of patients)
- The safety analysis from 1,575 adults and 615 children confirmed that GI intolerance was not dependent on dosing frequency per se, but the 400 mg single dose was associated with more GI symptoms 6
Clinical Recommendation
For most infections, administer cefixime 200 mg twice daily rather than 400 mg once daily to minimize gastrointestinal side effects while maintaining equivalent efficacy 5.
Specific Clinical Scenarios
Uncomplicated Gonorrhea
- Single dose of 400 mg is appropriate and FDA-approved 1
- However, note that cefixime treatment failures have been documented, particularly with elevated MICs (≥0.12 μg/mL), with failure rates as high as 25% 7
- Current guidelines from 2024 suggest cefixime as an alternative only when ceftriaxone is unavailable 8
Urinary Tract Infections
- Either 400 mg OD or 200 mg BID is effective 5
- Prefer 200 mg BID for better GI tolerability
Respiratory Tract Infections & Otitis Media
- Pediatric dosing: 8 mg/kg/day, can be given once daily or divided BID 1
- For otitis media specifically: Use the suspension formulation, as it achieves higher peak blood levels than tablets at the same dose 1
Important Caveats
- Renal impairment: Dose adjustment required for creatinine clearance <60 mL/min 1
- Duration: For Streptococcus pyogenes infections, treat for at least 10 days regardless of dosing frequency 1
- Food: May be administered without regard to food 1
Bottom Line Algorithm
- For gonorrhea: 400 mg single dose (but consider ceftriaxone as first-line given resistance concerns)
- For all other indications: 200 mg BID preferred over 400 mg OD due to better GI tolerability
- Pediatric patients: 8 mg/kg/day; can use once daily for convenience or divide BID for better tolerance
- Otitis media in children: Must use suspension formulation, not tablets